Lataa...
Stopping or Reporting Early for Positive Results in Randomized Clinical Trials: The National Cancer Institute Cooperative Group Experience From 1990 to 2005
Randomized clinical trials are designed with stopping boundaries to guide data monitoring committees with their decision making concerning ongoing trials. In particular, when extremely positive results are seen and a boundary is crossed, the data monitoring committee may recommend releasing the resu...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society of Clinical Oncology
2009
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2668973/ https://ncbi.nlm.nih.gov/pubmed/19237631 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.19.5339 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|